Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01046825 · ClinicalTrials.gov registry record · Phase 2
Mature B-Cell Lymphoma And Leukemia Study III
A Phase 2 study of Mature B-Cell Lymphoma, sponsored by St. Jude Children's Research Hospital.
- Active
- Registry status
- Phase 2
- Development phase
- 128
- Enrollment target
- 4
- Study locations
NCT01046825 is a Phase 2 study of Mature B-Cell Lymphoma that is active but no longer recruiting, run by St. Jude Children's Research Hospital. The registered enrollment target is 128 participants. The trial reports 4 study locations across 3 states.
The verdict
NCT01046825, a Phase 2 study of Mature B-Cell Lymphoma, is active but no longer recruiting, sponsored by St. Jude Children's Research Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 128 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a phase III clinical trial using risk-adapted therapy. Treatment outcomes for children with B-cell NHL are excellent. Further improvements in outcome will likely be achieved through more focused study of the biology of the tumors and prospective studies of the late effects of treatment. Toward this end, this study features a spectrum of prospective biologic and late effect studies performed in patients treated with a modified regimen derived from the very successful LMB-96 regimen.
Conditions Studied
Interventions
- DRUG COPAD
- DRUG COP, COPD M3, CYM
- DRUG COP, COPADM8, CYVE
Study Locations (4)
Other
- Children's Cancer Hospital - Cairo
- National University Health System - Singapore
California
- Rady Children's Hospital San Diego - San Diego
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2010-09-09 |
| Est. Completion | 2027-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01046825
The ClinicalTrials.gov registry entry for NCT01046825 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mature B-Cell Lymphoma appearing as the primary indexed condition, and to 3 interventions - of which COPAD is the first listed.
NCT01046825 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Other, California, Tennessee.
Frequently Asked Questions
What is clinical trial NCT01046825 about?
NCT01046825 is a clinical study titled "Mature B-Cell Lymphoma And Leukemia Study III". This is a phase III clinical trial using risk-adapted therapy. Treatment outcomes for children with B-cell NHL are excellent. Further improvements in outcome will likely be achieved through more focused study of the biology of the tumors and prospective studies of the late effects of treatment. Towa...
What is the current status of trial NCT01046825?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 128 participants. The study started on 2010-09-09. Estimated completion is 2027-08.
What conditions does trial NCT01046825 study?
This clinical trial studies the following conditions: Mature B-Cell Lymphoma.
What interventions are being tested in trial NCT01046825?
The interventions under investigation include: COPAD (DRUG), COP, COPD M3, CYM (DRUG), COP, COPADM8, CYVE (DRUG).
Who is sponsoring clinical trial NCT01046825?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01046825 being conducted?
This trial has 4 study locations across California, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.